[Development of hypertension in patients with mesangioproliferative glomerulonephritis].
Pap
I
I
Klinik für Innere Medizin, Bezirkskrankenhauses Magdeburg.
Gärtner
U
U
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001437:Bacteriuria / Q000503:physiopathology; D001794:Blood Pressure / Q000187:drug effects; D004906:Erythrocyte Count / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D015432:Glomerulonephritis, Membranoproliferative / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D006978:Hypertension, Renovascular / Q000503:physiopathology*; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000627:therapeutic use; D011507:Proteinuria / Q000503:physiopathology; D014556:Urine / Q000166:cytology
D011239:Prednisolone; D001379:Azathioprine
Hypertonieentwicklung bei Patienten mit mesangioproliferativer Glomerulonephritis.